Inhibition of IL-32 and TSLP production through the attenuation of caspase-1 activation in an animal model of allergic rhinitis by Naju Jjok (Polygonum tinctorium)

Jeong,Hyun-Ja; Oh,Hyun-A; Lee,Byung-Joo; Kim,Hyung-Min

doi:10.3892/ijmm.2013.1548

Inhibition of IL-32 and TSLP production through the attenuation of caspase-1 activation in an animal model of allergic rhinitis by Naju Jjok (Polygonum tinctorium)

Authors:
- Hyun-Ja Jeong
- Hyun-A Oh
- Byung-Joo Lee
- Hyung-Min Kim
View Affiliations

Affiliations: Biochip Research Center and Inflammatory Diseases Research Center, Hoseo University, Asan, Chungnam 336-795, Republic of Korea, Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea
Published online on: November 5, 2013 https://doi.org/10.3892/ijmm.2013.1548
Pages: 142-150

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In this study, we investigated the effects of Naju Jjok (Polygonum tinctorium Lour., NJJ) on interleukin (IL)-32 and thymic stromal lymphopoietin (TSLP) levels associated with allergic rhinitis (AR). Using female BALB/c mice, we created an animal model of ovalbumin (OVA)-induced AR. Prior to the callenge with OVA, the mice were administered, either nasally or orally with NJJ. In addition, we also used the eosinophilic cells line, Eol-1, stimulated with granulocyte‑macrophage colony-stimulation factor (GM-CSF). The mRNA and protein levels of inflammatory cytokines and markers [interleukin (IL)-32, IL-4, macrophage-inflammatory protein-2 (MIP-2), intercellular adhesion molecule-1 (ICAM-1), and cyclooxygenase-2 (COX-2)] were measured by RT-PCR and western blot analysis, respectively and serum levels were measured by ELISA. The increased levels of IL-32 in the mice with AR and in the stimulated eosinophilic cell line, Eol-1, were significantly reduced by NJJ. TSLP levels were also decreased following the oral administration of NJJ. Mice orally administered NJJ showed markedly alleviated clinical symptoms, such as a reduced number of nasal rubs, decreased spleen weight, decreased serum immunoglobulin E (IgE) levels and decreased serum histamine levels. The oral administration of NJJ significantly decreased the IL-4 levels, while increasing the interferon-γ levels in the spleen. The increased number of eosinophils and mast cells infiltrating the nasal mucosal tissue of the mice with AR were decreased following the oral administration of NJJ. NJJ effectively attenuated caspase-1 activity in the mice with AR and in the stimulated Eol-1 cells. The oral administration of NJJ significantly reduced the levels of inflammatory markers, such as MIP-2, ICAM-1 and COX-2. Furthermore, the intranasal administration of NJJ significantly reduced the early phase response to allergen exposure, such as nasal rubs, IgE production and histamine release, as well as the late phase responses, such as the expression of inflammatory markers. In conclusion, these data demonstrate that NJJ may play a regulatory role in nasal inflammation.

View Figures

View References

1	Varney VA, Jacobson MR, Suddarick RM, et al: Immunohistology of nasal mucosa following allergen induced rhinitis. Am Rev Respir Dis. 146:170–175. 1992. View Article : Google Scholar : PubMed/NCBI
2	Sim TC, Grant JA, Hilsmeier KA, Fukuda Y and Alam R: Pro-inflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med. 149:339–344. 1994. View Article : Google Scholar : PubMed/NCBI
3	Gupta S, Feng L, Yoshimura T, Redick J, Fu SM and Rose CE Jr: Intra-alveolar macrophage-inflammation peptide 2 induces rapid neutrophil localization in the lung. Am J Respir Cell Mol Biol. 15:656–663. 1996. View Article : Google Scholar : PubMed/NCBI
4	Durham SR, Ying S, Varney VA, et al: Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophase colony stimulating factors in the nasal mucosa after local allergen provocation. J ImmunoI. 148:2390–2394. 1992.
5	Bacon AS, McGill JI, Anderson DF, Baddeley S, Lightman SL and Holgate ST: Adhesion molecules and relationship to leukocyte levels in allergic eye disease. Invest Ophthalmol Vis Sci. 39:322–330. 1998.PubMed/NCBI
6	Tai PC and Spry CJ: The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils. Clin Exp Immunol. 80:426–434. 1990.
7	Jeong HJ, Shin SY, Oh HA, Kim MH, Cho JS and Kim HM: IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Path. 224:553–563. 2011. View Article : Google Scholar : PubMed/NCBI
8	Marcondes AM, Mhyre AJ, Stirewalt DL, Kim SH, Dinarello CA and Deeg HJ: Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc Natl Acad Sci USA. 105:2865–2870. 2008. View Article : Google Scholar : PubMed/NCBI
9	Bae S, Kang D, Hong J, et al: Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection. Cytokine. 58:79–86. 2012. View Article : Google Scholar : PubMed/NCBI
10	Heinhuis B, Koenders MI, van Riel PL, et al: Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis. 70:660–667. 2011. View Article : Google Scholar : PubMed/NCBI
11	Kim SH, Han SY, Azam T, Yoon DY and Dinarello CA: Interleukin-32: a cytokine and inducer of TNF alpha. Immunity. 22:131–142. 2005.PubMed/NCBI
12	Netea MG, Azam T, Ferwerda G, et al: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA. 102:16309–16314. 2005. View Article : Google Scholar : PubMed/NCBI
13	Nishida A, Andoh A, Shioya M, Kim-Mitsuyama S, Takayanagi A and Fujiyama Y: Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 294:G831–G838. 2008. View Article : Google Scholar : PubMed/NCBI
14	Heinhuis B, Koenders MI, van den Berg WB, Netea MG, Dinarello CA and Joosten LA: IL-32 contains a typical alpha-helix bundle structure that resembles the focal adhesion targeting region of focal adhesion kinase-1. J Biol Chem. 287:5733–5743. 2012. View Article : Google Scholar
15	Ying S, O’Connor B, Ratoff J, et al: Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol. 181:2790–2798. 2008. View Article : Google Scholar : PubMed/NCBI
16	Soumelis V, Reche PA, Kanzler H, et al: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 3:673–680. 2002.PubMed/NCBI
17	Bunyavanich S, Melen E, Wilk JB, et al: Thymic stromal lymphopoietin (TSLP) is associated with allergic rhinitis in children with asthma. Clin Mol Allergy. 9:12011. View Article : Google Scholar : PubMed/NCBI
18	Moon PD and Kim HM: Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-κB pathway in mast cells. Cytokine. 54:239–243. 2011.PubMed/NCBI
19	Song YH, Nam SY, Choi Y, Kim JH, Kim YS and Jeong HJ: Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug. TANG. 2:52–60. 2012.
20	Jeong HJ, Nam SY, Oh HA, et al: Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro. Arthritis Res Ther. 14:R2592012. View Article : Google Scholar : PubMed/NCBI
21	Iwaki K, Satomi KM, Kohno K, Ushio S and Fukuda S: Antimicrobial activity of Polygonum tinctorium Lour: extract against oral pathogenic bacteria. J Nat Med. 60:121–125. 2006.
22	Satomi KM, Kimoto T, Micallef MJ, et al: Prevention of azoxymethane-induced intestinal tumors by a crude ethyl acetate-extract and tryptanthrin extracted from Polygonum tinctorium Lour. Anticancer Res. 21:3295–3300. 2001.PubMed/NCBI
23	Kataoka M, Hirata K, Kunikata T, et al: Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils. J Gastroenterol. 36:5–9. 2001. View Article : Google Scholar : PubMed/NCBI
24	Kim HM, Hong DR and Lee EH: Inhibition of mast cell-dependent anaphylactic reactions by the pigment of Polygonum tinctorium (Chung-Dae) in rats. Gen Pharmacol. 31:361–365. 1998. View Article : Google Scholar : PubMed/NCBI
25	Miyata M, Hatsushika K, Ando T, et al: Mast cell regulation of epithelial TSLP expression plays an important role in the development of allergic rhinitis. Eur J Immunol. 38:1487–1492. 2008. View Article : Google Scholar : PubMed/NCBI
26	Han NR, Kim HM and Jeong HJ: Thymic stromal lymphopoietin is regulated by the intracellular calcium. Cytokine. 59:215–217. 2012. View Article : Google Scholar : PubMed/NCBI
27	Spada CS, Nieves AL, Krauss AH and Woodward DF: Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol. 55:183–191. 1994.PubMed/NCBI
28	Sugimoto H, Shichijo M, Iino T, et al: An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther. 305:347–352. 2003. View Article : Google Scholar : PubMed/NCBI
29	Melvin TA and Ramanathan M Jr: Role of innate immunity in the pathogenesis of allergic rhinitis. Curr Opin Otolaryngol Head Neck Surg. 20:194–198. 2012. View Article : Google Scholar : PubMed/NCBI
30	Isobe Y, Kato T and Arita M: Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation. Front Immunol. 3:2702012. View Article : Google Scholar : PubMed/NCBI
31	Moshkovits I, Shik D, Itan M, et al: CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis. Mucosal Immunol. Jul 3–2013.(Epub ahead of print). View Article : Google Scholar
32	Bystrom J, Patel SY, Amin K and Bishop-Bailey D: Dissecting the role of eodinophil cationic protein in upper airway disease. Curr Opin Allergy Clin Immunol. 12:18–23. 2012. View Article : Google Scholar
33	Soyka MB, Treis A, Eiwegger T, et al: Regulation and expression of IL-32 in chronic rhinosinusitis. Allergy. 67:790–798. 2012. View Article : Google Scholar : PubMed/NCBI
34	Nomura K, Kojima T, Fuchimoto J, Obata K, Keira T, Himi T and Sawada N: Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines. Laryngoscope. 122:1185–1192. 2012. View Article : Google Scholar : PubMed/NCBI
35	Oh HA, Kim HM and Jeong HJ: Alleviation of allergic rhinitis symptoms with Pyeongwee-San extract (KMP6). Immunopharmacol Immunotoxicol. 34:135–142. 2012. View Article : Google Scholar : PubMed/NCBI
36	Vashisht P and Casale T: Omalizumab for treatment of allergic rhinitis. Expert Opin Biol Ther. 13:933–945. 2013. View Article : Google Scholar : PubMed/NCBI
37	Sollberger G, Strittmatter GE, Garstkiewicz M, Sand J and Beer HD: Caspase-1: the inflammasome and beyond. Innate Immun. May 15–2013.(Epub ahead of print).
38	Grzegorczyk J, Kowalski ML, Pilat A and Iwaszkiewicz J: Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis. Mediators Inflamm. 11:225–233. 2002. View Article : Google Scholar : PubMed/NCBI
39	Han NR, Kim HM and Jeong HJ: Kanamycin activates caspase-1 in NC/Nga mice. Exp Dermatol. 20:659–663. 2011. View Article : Google Scholar : PubMed/NCBI
40	Cunha TM, Talbot J, Pinto LG, et al: Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1β maturation. Mol Pain. 6:632010.PubMed/NCBI
41	Lee EJ, Ji GE and Sung MK: Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells. Inflamm Res. 59:847–854. 2010. View Article : Google Scholar : PubMed/NCBI
42	Gong JH, Shin D, Han SY, Kim JL and Kang YH: Kaempferol suppresses eosionphil infiltration and airway inflammation in airway epithelial cells and in mice with allergic asthma. J Nutr. 142:47–56. 2012. View Article : Google Scholar : PubMed/NCBI
43	Kunikata T, Tatefuji T, Aga H, Iwaki K, Ikeda M and Kurimoto M: Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur J Pharmacol. 410:93–100. 2000. View Article : Google Scholar : PubMed/NCBI
44	Kim MH, Choi YY, Yang G, Cho IH, Nam D and Yang WM: Indirubin, a purple 3,2-bisindole, inhibited allergic contact dermatitis via regulating Thelper(Th)-mediated immune system in DNCB-induced model. J Ethnopharmacol. 145:214–219. 2013. View Article : Google Scholar : PubMed/NCBI